Analysis of Anxiety and Depression Status in Patients Undergoing Radiotherapy During the COVID-19 Epidemic

Yang, Liping; Yang, Jing; He, Jian; Zhou, Yan; Zhang, Yangyang; Sun, Biao; Gao, Jing; Qian, Liting

doi:10.3389/fpsyt.2021.771621

Cited by 9 publications

(7 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 27,590 cases were included, and the sample size of each study ranged from 14 to 6231 participants. As for risk of bias, 11, 24 , 27 , 29 , 31 , 34 , 37 , 38 , 40 , 47 , 50 , 56 14, 23 , 25 , 28 , 32 , 33 , 35 , 41 , 42 , 43 , 44 , 49 , 52 , 54 , 55 and 15 19 , 20 , 21 , 22 , 26 , 30 , 36 , 39 , 45 , 46 , 48 , 51 , 53 studies had high, unclear, and low risks, respectively (Table S6 ). Overall, the risk of bias for the included studies was relatively small, indicating moderate methodological quality.…”

Section: Resultsmentioning

confidence: 99%

The prevalence of psychological disorders among cancer patients during the COVID‐19 pandemic: A meta‐analysis

Zhang

Liu²,

Tong³

et al. 2022

Psycho-Oncology

View full text Add to dashboard Cite

Purpose We aimed to assess the prevalence rate (PR) of depression, anxiety, posttraumatic stress disorder (PTSD), insomnia, distress, and fear of cancer progression/recurrence among patients with cancer during the COVID‐19 pandemic. Methods Studies that reported the PR of six psychological disorders among cancer patients during the COVID‐19 pandemic were searched in PubMed, Embase, PsycINFO, and Web of Science databases, from January 2020 up to 31 January 2022. Meta‐analysis results were merged using PR and 95% confidence intervals, and heterogeneity among studies was evaluated using I 2 and Cochran's Q test. Publication bias was examined using funnel plots and Egger's tests. All data analyses were performed using Stata14.0 software. Results Forty studies with 27,590 participants were included. Pooled results showed that the PR of clinically significant depression, anxiety, PTSD, distress, insomnia, and fear of cancer progression/recurrence among cancer patients were 32.5%, 31.3%, 28.2%, 53.9%, 23.2%, and 67.4%, respectively. Subgroup analysis revealed that patients with head and neck cancer had the highest PR of clinically significant depression (74.6%) and anxiety (92.3%) symptoms. Stratified analysis revealed that patients with higher education levels had higher levels of clinically significant depression (37.2%). A higher level of clinically significant PTSD was observed in employed patients (47.4%) or female with cancer (27.9%). Conclusion This meta‐analysis evaluated the psychological disorders of cancer patients during the COVID‐19 outbreak. Therefore, it is necessary to develop psychological interventions to improve the mental health of cancer patients during the pandemic.

show abstract

Section: Resultsmentioning

confidence: 99%

The prevalence of psychological disorders among cancer patients during the COVID‐19 pandemic: A meta‐analysis

Zhang

Liu²,

Tong³

et al. 2022

Psycho-Oncology

View full text Add to dashboard Cite

show abstract

“…A significant increase in the experience of isolation and a decrease in emotional functions and the general quality of life were observed during the Covid-19 lockdown in cancer patients [ 15 , 253 , 254 , 264 , 268 , 273 , 277 , 278 , 282 , 287 ].…”

Section: Resultsmentioning

confidence: 99%

“…The pandemic has also led to a great amount of anxiety and fear among both healthcare staff and patients. This is not to be underestimated because it can affect the proper work of healthcare staff and may contribute to interruptions or refusal of treatment by patients [ 258 , 287 ]…”

Section: Discussionmentioning

confidence: 99%

Covid-19 and radiotherapy: a systematic review after 2 years of pandemic

Piras¹,

Venuti

D’Aviero³

et al. 2022

Clin Transl Imaging

View full text Add to dashboard Cite

Introduction Following the Covid-19 pandemic spread, changes in clinical practice were necessary to limit the pandemic diffusion. Also, oncological practice has undergone changes with radiotherapy (RT) treatments playing a key role. Although several experiences have been published, the aim of this review is to summarize the current evidence after 2 years of pandemic to provide useful conclusions for clinicians. Methods A Pubmed/MEDLINE and Embase systematic review was conducted. The search strategy was “Covid AND Radiotherapy” and only original articles in the English language were considered. Results A total of 2.733 papers were obtained using the mentioned search strategy. After the complete selection process, a total of 281 papers were considered eligible for the analysis of the results. Discussion RT has played a key role in Covid-19 pandemic as it has proved more resilient than surgery and chemotherapy. The impact of the accelerated use of hypofractionated RT and telemedicine will make these strategies central also in the post-pandemic period.

show abstract

“…Furthermore, anxiety and depression in cancer patients are associated with poorer quality of life [ 44 , 45 ] and unfavorable prognosis [ 3 , 46 ]. Radiotherapy, chemotherapy and other treatments can further increase the psychological burden of cancer patients [ 6 , 47 , 48 ]. Therefore, the psychological health of cancer patients before and during the treatment process must be evaluated.…”

Section: Discussionmentioning

confidence: 99%

Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic

Qiao

Gao

Tong

et al. 2022

Support Care Cancer

View full text Add to dashboard Cite

Objection The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy. Methods Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression. Results A total of 112 patients with thyroid cancer were included. Of these, 72.32% ( n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression. Conclusions The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients. Supplementary information The online version contains supplementary material available at 10.1007/s00520-022-07422-7.

show abstract

Analysis of Anxiety and Depression Status in Patients Undergoing Radiotherapy During the COVID-19 Epidemic

Cited by 9 publications

References 26 publications

The prevalence of psychological disorders among cancer patients during the COVID‐19 pandemic: A meta‐analysis

The prevalence of psychological disorders among cancer patients during the COVID‐19 pandemic: A meta‐analysis

Covid-19 and radiotherapy: a systematic review after 2 years of pandemic

Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic

Contact Info

Product

Resources

About